Growth Metrics

Fulgent Genetics (FLGT) Accumulated Expenses (2016 - 2025)

Fulgent Genetics (FLGT) has disclosed Accumulated Expenses for 11 consecutive years, with $4.4 million as the latest value for Q4 2025.

  • Quarterly Accumulated Expenses fell 24.47% to $4.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.4 million through Dec 2025, down 24.47% year-over-year, with the annual reading at $4.4 million for FY2025, 24.47% down from the prior year.
  • Accumulated Expenses hit $4.4 million in Q4 2025 for Fulgent Genetics, down from $23.0 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $30.7 million in Q4 2023 to a low of $1.6 million in Q1 2025.
  • Historically, Accumulated Expenses has averaged $15.1 million across 5 years, with a median of $17.7 million in 2021.
  • Biggest five-year swings in Accumulated Expenses: skyrocketed 361.03% in 2023 and later tumbled 81.4% in 2024.
  • Year by year, Accumulated Expenses stood at $17.7 million in 2021, then tumbled by 62.31% to $6.7 million in 2022, then surged by 361.03% to $30.7 million in 2023, then crashed by 81.12% to $5.8 million in 2024, then dropped by 24.47% to $4.4 million in 2025.
  • Business Quant data shows Accumulated Expenses for FLGT at $4.4 million in Q4 2025, $23.0 million in Q3 2025, and $5.0 million in Q2 2025.